Top

Published in:

01-02-2004 | Poster presentation

Acute and high-dose therapy of urinary trypsin inhibitor could inhibit vascular endothelial cell disorders in critical illness

Authors: M Abe, M Ishikawa, Y Soga, H Suga, T Nakagawa, T Suzuki

Published in: Critical Care | Special Issue 1/2004

Excerpt

Urinary trypsin inhibitor (UTI) (MIRACLID^®, Mochida Corp., Tokyo, Japan), an elastase inhibitor extracted from human urine, has been used to treat for patients with acute pancreatitis or acute circulatory failure since more than 15 years ago in Japan. …

Title: Acute and high-dose therapy of urinary trypsin inhibitor could inhibit vascular endothelial cell disorders in critical illness
Authors: M Abe
M Ishikawa
Y Soga
H Suga
T Nakagawa
T Suzuki
Publication date: 01-02-2004
Publisher: BioMed Central
Published in: Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc2666

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Acute and high-dose therapy of urinary trypsin inhibitor could inhibit vascular endothelial cell disorders in critical illness

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2004

The confounding effect of hyperchloraemia on the base deficit in diabetic ketoacidosis

Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome in patients with systemic inflammatory response syndrome

Post-traumatic stress disorder after medical intensive care

Neuropsychological testing in the locked-in syndrome: preliminary results from a feasability study

Fluid resuscitation with colloids of different molecular weight in septic shock

Patient outcome after reorganization of a medical intensive care unit